Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026)

Bio-Rad Laboratories' (BIO) quarterly Other Non-Current Assets came in at $102.8 million in Q1 2026, down 0.87% year-on-year from $103.7 million in Q1 2025, and little changed on a QoQ basis from $102.7 million in Q4 2025.

Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Bio-Rad Laboratories (BIO) has 18 years of Other Non-Current Assets data on file, last reported at $102.8 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 0.87% year-over-year to $102.8 million in Q1 2026; TTM through Mar 2026 was $102.8 million, a 0.87% decrease from a year earlier, with the FY2025 full-year figure at $102.7 million, up 0.79% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $102.8 million, roughly flat from $102.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BIO reached as high as $109.0 million in Q3 2025 and fell as low as $92.9 million in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $100.8 million across 5 years, with a median of $101.8 million in 2022.
  • On a YoY basis, Other Non-Current Assets climbed as much as 12.73% in 2022 and fell as far as 9.21% in 2022.
  • Year by year, Other Non-Current Assets stood at $94.6 million in 2022, then advanced by 0.32% to $94.9 million in 2023, then climbed by 7.38% to $101.9 million in 2024, then rose by 0.79% to $102.7 million in 2025, then rose by 0.1% to $102.8 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $102.8 million in Q1 2026, $102.7 million in Q4 2025, and $109.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 3.17 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 738.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 285.90 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 828.89 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.25 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 164.00 Mn
10 Bio-Rad Laboratories 8.53 Bn 6.97 Bn 309.40 Mn 102.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 102.80 Mn
Dec 31, 2025 102.70 Mn
Sep 30, 2025 109.00 Mn
Jun 30, 2025 107.90 Mn
Mar 31, 2025 103.70 Mn
Dec 31, 2024 101.90 Mn
Sep 30, 2024 103.62 Mn
Jun 30, 2024 98.19 Mn
Mar 31, 2024 92.87 Mn
Dec 31, 2023 94.90 Mn
Sep 30, 2023 98.47 Mn
Jun 30, 2023 100.06 Mn
Mar 31, 2023 95.51 Mn
Dec 31, 2022 94.60 Mn
Sep 30, 2022 101.77 Mn
Jun 30, 2022 100.89 Mn
Mar 31, 2022 103.93 Mn
Dec 31, 2021 104.20 Mn
Sep 30, 2021 106.63 Mn
Jun 30, 2021 99.07 Mn